We are live on
!
Find out more
AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
43 hedge funds and large institutions have $3.1M invested in Accelerate Diagnostics in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
250% more call options, than puts
Call options by funds: $7K | Put options by funds: $2K
9% less funds holding
Funds holding: 47 → 43 (-4)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
45% less capital invested
Capital invested by funds: $5.69M → $3.1M (-$2.58M)
50% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 12
Holders
43
Holders Change
-4
Holders Change %
-8.51%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
12
Closed
7
Calls
$7K
Puts
$2K
Net Calls
+$5K
Net Calls Change
+$8K
Top Buyers
| 1 |
Lido Advisors
Los Angeles,
California
|
+$186K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$29.2K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$11.9K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.73K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$1.66K |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$227K |
| 2 |
GAM
Griffin Asset Management
New York
|
-$172K |
| 3 |
Renaissance Technologies
New York
|
-$48.8K |
| 4 |
Jane Street
New York
|
-$26.9K |
| 5 |
Millennium Management
New York
|
-$17.9K |
